. Author manuscript; available in PMC: 2014 Jul 10.

Published in final edited form as: Insect Mol Biol. 2013 Dec 3;23(2):199–215. doi: 10.1111/imb.12073

Table 7.

Temephos LC₅₀ (μg/ml) among larvae treated with a dose of temephos as compared with larvae pre-treated with one of three inhibitors followed by a dose of temephos. Synergism ratio (SRLC₅₀) corresponds to temephos LC₅₀ divided by the inhibitor-treatment LC_50.

Treatment	Inhibitor	Target Enzymes		Solidaridad F₉	Calderitas F₉	Mérida F₉	New Orleans
Temephos	None			0.1989 (0.1457–0.2715)	0.1520 (0.1214–0.1901)	0.0434 (0.0313–0.0602)	0.0033 (0.0026–0.0041)
Temephos	DEM 150 μg/ml	GST		0.2276 (0.1619–0.3199)	0.1065 (0.0791–0.1432)	0.0271 (0.0194–0.0378)
			SRLC₅₀	0.8739	1.4272	1.601
Temephos	PBO 5 μg/ml	CYP		1.1754 (0.3769–3.664)	0.2773 (0.1965–0.3913)	0.0936 (0.0608–0.1440)
			SRLC₅₀	0.1692	0.5481	0.4636
Temephos	DEF 1.5 μg/ml	CCE		0.0004 (0.0003–0.0007)	0.0020 (0.0014–0.0027)	0.0009 (0.0007–0.0011)
			SRLC₅₀	497.25	76.0	48.22